Rani Therapeutics (RANI) Short Interest Ratio & Short Volume $0.56 +0.03 (+5.45%) Closing price 04:00 PM EasternExtended Trading$0.53 -0.03 (-4.81%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Rani Therapeutics Short Interest DataRani Therapeutics (RANI) has a short interest of 980,000 shares, representing 3.12% of the float (the number of shares available for trading by the public). This marks a -86.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 1.10 million shares to cover all short positions.Current Short Interest980,000 sharesPrevious Short Interest7,130,000 sharesChange Vs. Previous Month-86.26%Dollar Volume Sold Short$525.18 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares63,210,000 sharesFloat Size31,460,000 sharesShort Percent of Float3.12%Today's Trading Volume1,709,118 sharesAverage Trading Volume1,096,903 sharesToday's Volume Vs. Average156% Short Selling Rani Therapeutics? Sign up to receive the latest short interest report for Rani Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRANI Short Interest Over TimeRANI Days to Cover Over TimeRANI Percentage of Float Shorted Over Time Rani Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025980,000 shares $525.18 thousand -86.3%3.1%0.5 $0.54 7/15/20257,130,000 shares $3.07 million +88.6%29.8%4 $0.43 6/30/20253,780,000 shares $1.94 million +4.1%14.2%8.3 $0.51 6/15/20253,630,000 shares $1.91 million +16.7%15.9%8.4 $0.53 5/31/20253,110,000 shares $1.73 million +5.8%13.7%7.6 $0.56 5/15/20252,940,000 shares $1.68 million +25.1%12.9%7.6 $0.57 4/30/20252,350,000 shares $2.61 million +0.4%10.3%3.4 $1.11 4/15/20252,340,000 shares $2.83 million -2.5%10.3%2.8 $1.21 3/31/20252,400,000 shares $3.02 million +2.6%10.6%2.8 $1.26 3/15/20252,340,000 shares $3.53 million -5.3%10.4%2.6 $1.51 Get the Latest News and Ratings for RANI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rani Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/20252,470,000 shares $3.78 million -12.1%10.9%2.6 $1.53 2/15/20252,810,000 shares $5.20 million +48.7%12.4%2.8 $1.85 1/31/20251,890,000 shares $2.63 million -6.0%8.3%1.9 $1.39 1/15/20252,010,000 shares $2.63 million +34.9%8.8%3.7 $1.31 12/31/20241,490,000 shares $2.04 million -10.2%6.5%0.8 $1.37 12/15/20241,660,000 shares $2.76 million +8.5%7.3%0.9 $1.66 11/30/20241,530,000 shares $3.09 million -4.4%6.8%0.9 $2.02 11/15/20241,600,000 shares $3.63 million +7.4%7.1%0.9 $2.27 10/31/20241,490,000 shares $3.41 million -41.6%7.2%0.9 $2.29 10/15/20242,550,000 shares $5.41 million +223.4%12.3%1.7 $2.12 9/30/2024788,600 shares $1.70 million -1.1%5.3%14.1 $2.16 9/15/2024797,600 shares $1.89 million +6.5%5.3%14.5 $2.37 8/31/2024749,100 shares $2.40 million +1.4%5.0%13.7 $3.20 8/15/2024738,700 shares $1.98 million -0.1%5.0%13.9 $2.68 7/31/2024739,700 shares $2.09 million -0.5%5.5%11.4 $2.83 7/15/2024743,600 shares $2.97 million -1.8%6.2%8.1 $3.99 6/30/2024757,200 shares $2.88 million +1.6%6.6%5.6 $3.80 6/15/2024745,400 shares $3.00 million -4.8%6.5%5.1 $4.03 5/31/2024783,200 shares $4.31 million -10.1%6.8%5.3 $5.50 5/15/2024871,200 shares $4.82 million -29.7%7.5%5.9 $5.53 4/30/20241,240,000 shares $7.91 million -27.9%10.9%8.6 $6.38 4/15/20241,720,000 shares $9.91 million -10.4%14.7%13.5 $5.76 3/31/20241,920,000 shares $5.97 million +3.2%16.7%23.7 $3.11 3/15/20241,860,000 shares $6.17 million +8.8%16.2%23.6 $3.32 2/29/20241,710,000 shares $6.40 million +2.4%15.2%16.6 $3.74 2/15/20241,670,000 shares $5.68 million No Change14.8%16.3 $3.40 1/31/20241,670,000 shares $5.78 million +9.9%14.8%16.1 $3.46 1/15/20241,520,000 shares $5.17 million +11.8%13.5%16.2 $3.40 12/31/20231,360,000 shares $4.52 million No Change12.1%13.9 $3.32 12/15/20231,360,000 shares $3.86 million +5.4%12.1%14.3 $2.84Out of 18,347 Cryptocurrencies... This is the ONLY One (Ad)The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.Get the whole story on this "crypto market unicorn" right here. 11/30/20231,290,000 shares $2.55 million +8.4%7.6%15.7 $1.98 11/15/20231,190,000 shares $2.37 million -8.5%6.9%21.1 $1.99 10/31/20231,300,000 shares $2.55 million +17.1%7.6%24.7 $1.96 10/15/20231,110,000 shares $2.20 million +14.5%6.5%21 $1.98 9/30/2023969,500 shares $2.11 million +0.2%5.7%23.4 $2.18 9/15/2023967,300 shares $2.65 million -0.8%5.7%25.9 $2.74 8/31/2023975,000 shares $3.71 million +1.6%5.7%26.3 $3.80 8/15/2023959,400 shares $4.11 million -0.7%5.6%21.7 $4.28 7/31/2023965,700 shares $4.13 million -0.2%5.7%16.3 $4.28 7/15/2023967,500 shares $4.07 million +10.4%5.7%16.2 $4.21 6/30/2023876,100 shares $3.61 million +1.1%5.2%13.9 $4.12 6/15/2023866,700 shares $3.84 million -1.8%5.1%13.2 $4.43 5/31/2023882,500 shares $3.60 million +21.7%5.2%14.5 $4.08 5/15/2023724,900 shares $2.97 million +18.3%4.3%13.6 $4.10 4/30/2023612,700 shares $2.88 million +23.0%3.7%15.6 $4.70 4/15/2023498,200 shares $2.61 million +54.2%3.1%12 $5.24 3/31/2023323,200 shares $1.67 million +20.5%2.1%8.8 $5.16 3/15/2023268,200 shares $1.60 million -16.2%1.6%7.9 $5.95 2/28/2023320,000 shares $2.02 million -2.1%2.0%7.4 $6.30 2/15/2023326,800 shares $1.68 million -3.1%2.0%7.1 $5.13 1/31/2023337,400 shares $1.85 million -15.1%2.1%7.3 $5.49 1/15/2023397,600 shares $2.60 million -0.7%2.5%8.4 $6.54 12/30/2022400,200 shares $2.36 million -9.1%2.5%7.3 $5.90 12/15/2022440,400 shares $3.52 million +29.8%2.7%8.1 $8.00 11/30/2022339,400 shares $2.81 million +0.2%2.1%6.3 $8.28 11/15/2022338,900 shares $2.59 million -19.5%2.1%6.6 $7.64 10/31/2022420,900 shares $2.57 million +30.6%2.5%6.2 $6.10 10/15/2022322,400 shares $2.28 million +8.2%1.9%4.9 $7.08 9/30/2022298,100 shares $2.86 million +10.7%1.8%4.8 $9.58 9/15/2022269,400 shares $2.45 million -5.8%1.6%4.4 $9.11 8/31/2022286,100 shares $2.55 million -18.7%1.7%4.5 $8.90 8/15/2022351,800 shares $4.02 million +32.2%2.1%5.6 $11.44 7/31/2022266,100 shares $2.99 million +14.3%1.6%6.2 $11.25 7/15/2022232,900 shares $2.83 million +2.6%1.4%5.2 $12.14 6/30/2022227,000 shares $2.34 million +43.9%1.4%5.3 $10.33 6/15/2022157,700 shares $1.39 million -23.4%1.0%3.9 $8.83 5/31/2022205,800 shares $2.35 million +0.2%1.2%6.4 $11.40 5/15/2022205,400 shares $2.26 million +43.4%1.2%5.6 $11.00 4/30/2022143,200 shares $1.75 million -23.1%1.0%3.6 $12.23 4/15/2022186,100 shares $2.42 million -12.4%1.3%4.4 $13.00 3/31/2022212,400 shares $2.87 million -15.6%1.8%4.7 $13.50 3/15/2022251,600 shares $3.49 million +2.2%2.1%5 $13.89 2/28/2022246,100 shares $4.11 million -27.0%2.0%4.3 $16.69 2/15/2022337,300 shares $5.23 million -8.0%3.2%5.8 $15.50 1/31/2022366,800 shares $7.60 million -1.3%3.5%6 $20.73 1/15/2022371,800 shares $7.69 million -0.8%7.0%5.3 $20.67 12/31/2021374,700 shares $6.13 million No Change7.1%5.6 $16.35 RANI Short Interest - Frequently Asked Questions What is Rani Therapeutics' current short interest? Short interest is the volume of Rani Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 980,000 shares of RANI short. 3.12% of Rani Therapeutics' shares are currently sold short. Learn More on Rani Therapeutics' current short interest. What is a good short interest percentage for Rani Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.12% of Rani Therapeutics' floating shares are currently sold short. Is Rani Therapeutics' short interest increasing or decreasing? Rani Therapeutics saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 980,000 shares, a drop of 86.3% from the previous total of 7,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Rani Therapeutics' float size? Rani Therapeutics currently has issued a total of 63,210,000 shares. Some of Rani Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Rani Therapeutics currently has a public float of 31,460,000 shares. How does Rani Therapeutics' short interest compare to its competitors? 3.12% of Rani Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Rani Therapeutics: Genelux Corporation (6.37%), Compugen Ltd. (1.66%), Korro Bio, Inc. (21.68%), Spero Therapeutics, Inc. (2.61%), Fate Therapeutics, Inc. (8.57%), Seres Therapeutics, Inc. (15.50%), Immuneering Corporation (6.04%), Protalix BioTherapeutics, Inc. (5.26%), Inhibikase Therapeutics, Inc. (4.58%), Protara Therapeutics, Inc. (8.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Rani Therapeutics stock? Short selling RANI is an investing strategy that aims to generate trading profit from Rani Therapeutics as its price is falling. RANI shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rani Therapeutics? A short squeeze for Rani Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RANI, which in turn drives the price of the stock up even further. How often is Rani Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RANI, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies GNLX Short Squeeze CGEN Short Squeeze KRRO Short Squeeze SPRO Short Squeeze FATE Short Squeeze MCRB Short Squeeze IMRX Short Squeeze PLX Short Squeeze IKT Short Squeeze TARA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RANI) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rani Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access